Literature DB >> 3096985

Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity.

J F Tait, K Fujikawa.   

Abstract

We studied the ability of fragments of the light chain of human high molecular weight kininogen to bind to plasma prekallikrein. In a competitive fluorescence polarization assay, kallikrein-cleaved light chain (light chain-2; residues 49-255), a cyanogen bromide fragment (residues 185-242), and a tryptic peptide (T-7; residues 185-224) had binding affinities of approximately 20 nM, equivalent to the value for the intact light chain (residues 1-255) of high-molecular-weight kininogen. In contrast, fragments consisting of residues 49-184 and 243-255 showed no binding activity (Kd much greater than 1,000 nM). Direct titrations of fluorescein-labeled derivatives of light chain-2 and peptide T-7 with prekallikrein confirmed that T-7 retained full binding activity for prekallikrein (Kd = 12 +/- 2 nM for labeled light chain-2; Kd = 7 +/- 1 nM for labeled T-7). These results localize the binding site of high molecular weight kininogen for prekallikrein within a region of 40 amino acids (residues 185-224) that resides in the near carboxyl terminus of the light chain of kininogen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096985

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation.

Authors:  S Selvarajan; L R Lund; T Takeuchi; C S Craik; Z Werb
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

2.  Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.

Authors:  R W Colman; R A Pixley; S Najamunnisa; W Yan; J Wang; A Mazar; K R McCrae
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.

Authors:  F S Seaman; F A Baglia; J A Gurr; B A Jameson; P N Walsh
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

4.  Kininogen supports inflammation and bacterial spreading during Streptococccus Pyogenes Sepsis.

Authors:  Juliane Köhler; Claudia Maletzki; Dirk Koczan; Marcus Frank; Armin Springer; Carolin Steffen; Alexey S Revenko; A Robert MacLeod; Stefan Mikkat; Bernd Kreikemeyer; Sonja Oehmcke-Hecht
Journal:  EBioMedicine       Date:  2020-07-21       Impact factor: 8.143

5.  Anti-HK antibody reveals critical roles of a 20-residue HK region for Aβ-induced plasma contact system activation.

Authors:  Zu-Lin Chen; Pradeep Kumar Singh; Katharina Horn; Sidney Strickland; Erin H Norris
Journal:  Blood Adv       Date:  2022-05-24

6.  Inhibition of cell adhesion by high molecular weight kininogen.

Authors:  S Asakura; R W Hurley; K Skorstengaard; I Ohkubo; D F Mosher
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

7.  High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.

Authors:  E J Gustafson; H Lukasiewicz; Y T Wachtfogel; K J Norton; A H Schmaier; S Niewiarowski; R W Colman
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.